Editor-in-Chief:
Dr Bernard Binetruy, Directeur de Recherche INSERM, Faculte de Medecine, Inserm, France
Editorial Board:
Prof. Dr. Zeev Blumenfeld, Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel
Dr Pankaj Chaturvedi, Cell and Developmental Biology, University of Illinois at Urbana-Champaign, United States
Professor Michael Griswold, School of Molecular Biosciences, College of Sciences, Washington State University, WA, United States
Professor Dan Liebermann, The Fels Institute for Cancer Research and Molecular biology; and Medical Genetics & Molecular Biochemistry, Temple University School of Medicine, Philadelphia, PA, United States
Professor Joseph Locker, Pathology, University of Pittsburgh School of Medicine, United States
Dr Andres Matoso, Pathology, Johns Hopkins University, United States
Professor Colin McGuckin, Cell Therapy Research Institute, Lyon, France
Dr Louis Pelus, Department of Microbiology and Immunology, Indiana University School of Medicine, United States
Dr John Rossi, School of Biological Sciences Molecular and Cellular Biology, Beckman Research Institute of City of Hope, United States
Dr Dario Siniscalco, Department of Experimental Medicine, University of Campania, Naples, Italy
Professor Kiminobu Sugaya, College of Medicine, University of Central Florida, FL, United States
Prof. Dr. Marco Tatullo, Applied Technical Medical Sciences University of Bari, Italy
Professor Cory Xian, SUniSA Clinical & Health Sciences, University of South Australia, Australia
Professor Martin Yarmush, Biomedical Engineering, Rutgers University, United States
Professor John Zaia, Centre for Gene Therapy, City of Hope, United States
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})
![RegMedNet: Everything regenerative medicine and advanced therapies, all in one place]({"type":"image" , "src" : "/sda/112453/journalad-promotion-regmednet.png"})